Cardiology

Results of ILUMIEN III trial presented

Although percutaneous coronary intervention (PCI) is most commonly guided by angiography alone, results from a new study investigating adjunctive imaging modalities showed that the use of a novel optical coherence tomography ...

Cardiology

Achieving optimal medical tx before PCI beneficial in CAD

(HealthDay)—In patients with coronary artery disease (CAD), achievement of optimal medical therapy (OMT) before implantation of a drug-eluting stent significantly reduces subsequent cardiac events, according to a study ...

Cardiology

Deferred stenting shows no clinical benefit

Delayed or deferred stent implantation in patients experiencing the deadliest form of heart attack—ST-segment elevation myocardial infarction (STEMI)—failed to reduce death from any cause, hospitalization for heart failure, ...

Cardiology

Guidelines updated on duration of dual antiplatelet Tx in CAD

(HealthDay)—The American College of Cardiology and the American Heart Association Task Force on Clinical Practice Guidelines has updated the recommendations regarding duration of dual antiplatelet therapy (DAPT) for patients ...

Cardiology

Long duration dual antiplatelet treatment increases bleeding

(HealthDay)—Routine use of dual antiplatelet therapy (DAPT) beyond six months after second generation drug-eluting stent (DES) implantation yields mixed clinical results, according to a review published in the October issue ...

Cardiology

Review: Short vs. long duration dual antiplatelet Tx after stent

(HealthDay)—Dual antiplatelet therapy (DAPT) continued beyond six months after drug-eluting stent implantation is associated with reduced stent thrombosis and myocardial infarction but also increased bleeding and all-cause ...

Cardiology

Six-month dual antiplatelet tx noninferior to 24-month DAPT

(HealthDay)—For aspirin-sensitive patients undergoing everolimus-eluting stent implantation, six-month dual antiplatelet therapy (DAPT) is noninferior to 24-month DAPT, according to a study published in the March 3 issue ...

page 2 from 5